Technology-enabled Management Versus Usual Care for Blood Pressure
Recruiting · NCT05479461 · Interventional (participants receive a specific treatment) · Lead sponsor: Stanford University
View the official record on ClinicalTrials.gov →Interventions studied
Digital Hypertension Management SystemUsual Care
What this trial is about
Two arm parallel randomized clinical trial
Who can take part
Age range
30 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 30-90 yrs.
- Smartphone ownership
- Office SBP: ≥ 140 mm Hg
- ≤ 2 current anti-HTN meds
- Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)
- English or Spanish-speakers
Exclusion criteria
- Heart failure with reduced ejection fraction (EF \< 40%)
- ESRD (GFR \<15)
- Renal replacement therapy
- Pregnant
- Myocardial infarction or stroke within preceding 6 months
- Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months
- Prior solid organ transplantation
- At the clinical discretion of the investigators
- Enrolled in another clinical study
Where it is running
3 locations listed across 2 US states.
- Stanford Health Care - Palo Alto, California, United States
- Morehouse School of Medicine - Atlanta, Georgia, United States
- Lake Country Medical Group - Eatonton, Georgia, United States